 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
APO-go apomorphine solution is administered by either a subcutaneous (under the skin) injection or a continuous subcutaneous infusion using a small portable pump. APO-go must not be injected into a vein.
APO-go cannot be given in a tablet or any other oral formulation for the treatment of Parkinson's disease (unlike the other dopamine agonists available), due to the way it is metabolised. However, because it is injected under the skin into the fatty tissue, the effects can be seen much more quickly than in oral medicines. The apomorphine is transported rapidly to the bloodstream and directly to the part of the brain that requires dopamine stimulation.
An APO-go injection will usually start to work within five to ten minutes. Benefit from a single injection usually lasts for up to one hour. This rapid effect has resulted in apomorphine being called a 'rescue' drug, which can restore mobility, or prevent a period of disability from occurring.
For further information on the types of APO-go apomorphine treatment see: